Phase 1 Obesity Trial, Recruiting NCT07665879 Sponsor: Eli Lilly and Company Condition: Obesity
Back to Obesity

Phase 1 Obesity Trial, Recruiting

NCT07665879
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose HbA1c blood sugar level (a measure of average blood sugar over time) was below 6.5% at the initial screening appointment.
  • People with a body mass index (a measure of body weight relative to height) between 25 and 45 kg/m².
  • People whose body weight has been stable, changing by less than 5%, in the 3 months before screening.
  • People of any sex assigned at birth, including those who are or are not able to become pregnant, may be considered for this trial.

Who may not be able to join:

  • People who have type 1 or type 2 diabetes, a history of diabetic ketoacidosis, or a history of a dangerous high blood sugar emergency (hyperosmolar state or coma). Note: people with a history of gestational diabetes (diabetes during pregnancy) are still considered eligible.
  • People who have had, or currently have, inflammation of the pancreas (pancreatitis).
  • People who have a known significant problem with how their stomach empties food, or who regularly take medications that significantly affect how their digestive system moves food through.
  • People who have had, or are planning to have, surgery to treat obesity. Exceptions may apply for certain cosmetic procedures (liposuction, cryolipolysis, or abdominoplasty) if they took place more than 1 year before screening (confirm with trial site).
  • People who are not willing to follow the lifestyle and dietary rules required during the study.
  • People who were assigned female at birth and are currently breastfeeding.
  • People who were assigned female at birth and are currently pregnant, planning to become pregnant, or planning to breastfeed during the study, or people assigned male at birth who are planning to conceive a child during the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Phone: 1-317-615-4559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
24 June 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇩🇪 Germany 🇸🇪 Sweden

Primary endpoints

Change From Baseline In Hyperinsulinemic Euglycemic Clamp (HEC) Predicted Clamp-Derived Insulin Sensitivity (M-value)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov